Endonovo Therapeutics Inc (ENDV)

[John_Vallay]

Direct to consumer is a costly endeavor that would probably be in the $30-$50 customer acquisition cost when all is said and done. It would be great if Endonovo can start selling at amazon.com, but the product is not approved for such sales and distribution.

But that does not matter because the medical device has not been approved by the FDA for that type of sales and distribution. They have to go through a prescription.

I also question if the device has any viability. The reason I say that is because sales have been zero. The VA hospital, which is allowed to prescribe it to their patients has zero sales. Keep in mind the VA hospital has a large budget for medical devices to be used on their patients.

It's easy for the company or a paid representative to tell you how great the product is, or have a third party boast about the usage of a product, BUT SALES IS THE ONLY LEGITIMATE AND PROOF OF CONCEPT. Words and meaningless, sales have value above and beyond just money.

If the product is that good, as some have claimed, then I ask why is the FDA not allowing it to be sold directly to consumers?